See photos from Bristol Health Partners 2022 conference
Bristol Health Partners conference took place on 4 October 2022. Click on a photo to…
Bristol Health Partners 10th anniversary conference gets delegates moving
Bristol Health Partners Academic Health Science Centre welcomed more than 100 delegates to our…
Building community leadership in health research with under-served communities
A new project to build community leadership among communities that are often under-represented in health…
Continuity of care associated with improved prescribing for patients at risk of heart disease
People at risk of heart disease are more likely to be prescribed relevant medications…
Blood thinning drugs before removing a clot in stroke patients improves death rates at 90 days, study finds
A new systematic review and meta-analysis by an international group of researchers has found…
Eating Disorders HIT welcomes new Director
Our Eating Disorders Health Integration Team (EDHIT) is sorry to say goodbye to Helen Malson,…
Adverse health outcomes associated with long-term antidepressant use
Long-term antidepressant use may double the risk of heart disease, finds the most comprehensive…
Disabled households twice as likely to be struggling with cost of living crisis
New research shows that nearly half of disabled households (48%) have struggled to keep…
BBC Radio 1Xtra talks to Common Ambition Bristol for new podcast
Bristol’s Common Ambition project has been featured on a BBC Radio 1Xtra podcast. The episode…
Increase in non-COVID-19 respiratory infections predicted this winter
An increase in the number of non-COVID-19 respiratory infections should be expected this winter, say…
Award win for video about social media and young people’s mental health
A video created by Lizzy Winstone and members of NIHR ARC West and Bristol BRC’s…
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds
Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained…
